Xuesen Zhao

InstitutionBeijing Key Laboratory of Emerging Infectious Disease
AddressBeijing
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 2 publications in August 2020
    All Publications
    Bar chart showing 33 publications over 12 distinct years, with a maximum of 7 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Han J, Zhang N, Chen D, Gong Y, Li G, Kong Y, Pu L, Chen C, Liu J, Wang Q, Zhang J, Zhao X, Du J, Han K, Song C, Wang L, Hua M, Hao Y, Song R, Song Y, Yu F, Yang S, Xiong H, Zhang W, Gao GF, Zhang F, Li A, Zeng H, Bi Y. Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity. Sci China Life Sci. 2022 01; 65(1):223-226. PMID: 34086155.
      Citations: 1     Fields:    Translation:Humans
    2. Li Q, Yi D, Lei X, Zhao J, Zhang Y, Cui X, Xiao X, Jiao T, Dong X, Zhao X, Zeng H, Liang C, Ren L, Guo F, Li X, Wang J, Cen S. Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase. Acta Pharm Sin B. 2021 Jun; 11(6):1555-1567. PMID: 33614402.
      Citations: 5     
    3. Zheng M, Zhao X, Zheng S, Chen D, Du P, Li X, Jiang D, Guo JT, Zeng H, Lin H. Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion. Emerg Microbes Infect. 2020 Dec; 9(1):1567-1579. PMID: 32602823.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    4. Zhao X, Zheng S, Chen D, Zheng M, Li X, Li G, Lin H, Chang J, Zeng H, Guo JT. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2. J Virol. 2020 08 31; 94(18). PMID: 32641482.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    5. Zhao X, Chen D, Szabla R, Zheng M, Li G, Du P, Zheng S, Li X, Song C, Li R, Guo JT, Junop M, Zeng H, Lin H. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2. J Virol. 2020 08 31; 94(18). PMID: 32661139.
      Citations: 55     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    6. Chen D, Hou Z, Jiang D, Zheng M, Li G, Zhang Y, Li R, Lin H, Chang J, Zeng H, Guo JT, Zhao X. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus. Emerg Microbes Infect. 2019; 8(1):1511-1523. PMID: 31631785.
      Citations: 9     Fields:    Translation:HumansCells
    7. Zhao X, Sehgal M, Hou Z, Cheng J, Shu S, Wu S, Guo F, Le Marchand SJ, Lin H, Chang J, Guo JT. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses. J Virol. 2018 03 15; 92(6). PMID: 29263263.
      Citations: 45     Fields:    Translation:HumansCells
    8. Zhao X, Guo F, Comunale MA, Mehta A, Sehgal M, Jain P, Cuconati A, Lin H, Block TM, Chang J, Guo JT. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2. Antimicrob Agents Chemother. 2015 Jan; 59(1):206-16. PMID: 25348530.
      Citations: 29     Fields:    Translation:HumansCells
    9. Zhao X, Guo F, Liu F, Cuconati A, Chang J, Block TM, Guo JT. Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc Natl Acad Sci U S A. 2014 May 06; 111(18):6756-61. PMID: 24753610.
      Citations: 78     Fields:    Translation:HumansAnimalsCells
    10. Lin HX, Feng Y, Tu X, Zhao X, Hsieh CH, Griffin L, Junop M, Zhang C. Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry. Virus Res. 2011 Sep; 160(1-2):283-93. PMID: 21798295.
      Citations: 11     Fields:    Translation:HumansCells
    11. Lin HX, Feng Y, Wong G, Wang L, Li B, Zhao X, Li Y, Smaill F, Zhang C. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction. J Gen Virol. 2008 Apr; 89(Pt 4):1015-1024. PMID: 18343844.
      Citations: 35     Fields:    Translation:HumansCells